ARCADIA, Fla., Jan. 31, 2016 -- Sevigny & Associates Eye Care works to prevent common eye disease and provides early detection and management of diagnosed disorders. According to the Centers for Disease Control, macular degeneration, diabetic retinopathy, and glaucoma are the most common eye diseases. Early detection and intervention in these incurable conditions are key in reducing vision loss. The CDC predicts that age-related macular degeneration will affect up to 2.95 million individuals by 2020. Chronic disease such as diabetes and hypertension put patients at risk for diabetic retinopathy and glaucoma. According to the CDC, diabetic retinopathy is the leading cause of blindness among working adults.
According to Dr. Mark Sevigny of Sevigny & Associates Eye Care, regular eye examinations are the front line in the fight against degenerative eye diseases. "Some of our most terrible degenerative eye disease like glaucoma and macular degeneration begin without any symptoms. A patient may be feeling fine, and have no discernable change in their vision, but we can detect these disease in their earliest stages. Once detected, early intervention with topical medications like eye drops or oral medication can slow the progress of conditions like glaucoma or macular degeneration."
According to Dr. Sevigny, "Open and honest communication with an eye doctor is crucial to receiving appropriate care. When we know that a patient has other medical conditions that put them at risk for eye disease we can tailor our care accordingly. Patients may not like to admit that they are diabetic or hypertensive, but if they do not tell us, they are omitting an important piece of data that informs their care." Sevigny & Associates Eye Care uses state-of-the-art diagnostic techniques such as Ocular Coherence Tomography (OCT), Visual Evoked Potential (VEP), and electroretinography (ERG) to promote early detection of degenerative eye disease. These simple tests detect important changes in the eye structure or pressure that can indicate early stages of eye disease.
"About half of the people who are at risk, but do not already have a vision impairment that requires correction, are not coming in for regular eye examinations," stated Dr. Sevigny. "This is a critical mistake. By the time they notice vision loss, these diseases are fairly advanced. When patients with chronic conditions that place them at a greater risk for vision loss receive regular examinations, we can often prevent vision impairment with lifestyle changes, management of their disease, and early treatment for vision conditions."
To make an appointment, contact Sevigny & Associates Eye Care at 863-773-3322. Our Wauchula, Arcadia and Sebring eye clinics are open from 8:00 AM to 5:00 PM, Monday through Friday, and on Saturdays by appointment only. Visit Sevigny & Associates Eye Care online at http://7eeye.com/ for more information.
Sevigny & Associates Eye Care, 863-773-3322


Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
OpenAI Explores Massive Funding Round at $750 Billion Valuation
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 



